Archives
EIF-backed $105 million fund to support more Phase III last-stage trials
Abingworth, the life-sciences international investment firm, announced last Thursday that they have raised a new $105 million Abingworth Clinical Co-Development Fund (ACCF) - the result of an investment made by the European Investment Fund and others. The fund is designed to support late-stage clinical therapies through co-development companies.
Major banks funding Bitcoin startup on recording blockchain deals
A bitcoin startup Digital Asset Holdings has received funding from major banks. It will work closely with investors on research and commercialization of bitcoin technology applications. Digital Asset said that it has raised over $50 million funding from 13 investors. The list of investors includes JPMorgan Chase & Com, Citigroup Inc, BNP Paribas SA, CME Group Inc and Accenture Plc.
Overseas central banks are Fed's partner to accomplish rates
The Federal Reserve Bank have found a new partner in its struggle to confirm interest rate increase screens through the US economy. The trend of Fed borrowing billions daily to set a base under its standard policy rate has been conquered by foreign monetary authorities, Bloomberg said.
Ebola Vaccine Will Now Be Available As Gavi Signed $5 Million Deal To Prevent Future Outbreaks, Commits Merck To Keep 300,000 Vaccines Ready
Gavi, a world vaccine alliance, has made a $5 million deal with Merck regarding vaccine supply for future outbreaks. Merck has to provide 300,000 vaccines as a preparation to protect people from the next Ebola crisis.